May 3, 2018 / 8:55 PM / 3 months ago

BRIEF-Emergent BioSolutions Reports Q1 Adjusted Loss Per Share $0.03

May 3 (Reuters) - Emergent BioSolutions Inc:

* EMERGENT BIOSOLUTIONS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.10

* Q1 REVENUE $117.8 MILLION VERSUS I/B/E/S VIEW $140.4 MILLION

* SEES Q2 2018 REVENUE $205 MILLION TO $230 MILLION

* Q1 EARNINGS PER SHARE VIEW $0.22 — THOMSON REUTERS I/B/E/S

* REAFFIRMS FULL YEAR 2018 FINANCIAL FORECAST AND OPERATIONAL GOALS

* Q2 REVENUE VIEW $170.4 MILLION — THOMSON REUTERS I/B/E/S

* FY2018 EARNINGS PER SHARE VIEW $2.38, REVENUE VIEW $731.4 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below